Alkermes’ diverse portfolio of more than 20 commercial products reflects our powerful expertise in the development of innovative patient-inspired solutions. Among these are five key commercial products that provide unique treatment options for patients with debilitating diseases.
In addition, our rapidly evolving pipeline is equally promising in its potential to deliver products to address central nervous system (CNS) diseases, a therapeutic area where we have a proven track record. Click here to learn about our strong pipeline of innovative product candidates.
5 Key Commercial Products to Drive Growth:
There are currently five key commercial products that are the drivers to propel our company’s growth. Each of these products is unique in addressing patient needs in major disease areas.
Disease Areas and Approval Status
Proprietary Technologies that Span a Range of Therapeutic Areas
The Alkermes product portfolio includes more than 20 marketed products that use our proprietary technologies and span a range of major diseases.
This page is intended for healthcare professionals only.